![]() |
市場調査レポート
商品コード
1624070
速溶錠の市場規模・シェア・成長分析 (薬剤クラス別、適応症別、流通チャネル別、地域別):産業予測 (2025~2032年)Fast Melt Tablets Market Size, Share, Growth Analysis, By Drug Class (Anti-Psychotics, Anti-Epileptics), By Indication (CNS Diseases, GI Diseases), By Distribution channel, By Region - Industry Forecast 2025-2032 |
||||||
|
速溶錠の市場規模・シェア・成長分析 (薬剤クラス別、適応症別、流通チャネル別、地域別):産業予測 (2025~2032年) |
出版日: 2025年01月02日
発行: SkyQuest
ページ情報: 英文 268 Pages
納期: 3~5営業日
|
世界の速溶錠の市場規模は2023年に56億米ドルと評価され、2024年の61億米ドルから2032年には120億6,000万米ドルに成長し、予測期間 (2025-2032年) のCAGRは8.9%で成長する見通しです。
速溶錠 (ファストメルト錠剤) 市場は、水や咀嚼を必要とせずに溶ける固形の経口剤形に対する需要の増加により成長を遂げています。この革新的なソリューションは、活動的な人々、高齢者、嚥下困難な人々に対応し、さまざまな場面で薬物へのアクセス性を確保します。最近の経口溶解ドラッグデリバリーシステムの進歩により、薬物療法への迅速な介入、バイオアベイラビリティの改善、安定性の向上などの機能が強化されています。ユーザーフレンドリーな製造プロセスと安定した投与により、乗り物酔い、アレルギー発作、急性の咳など、迅速な作用発現が不可欠な症状への対応に理想的です。その結果、速溶錠は、効果的で便利な薬物療法を求める多様な人々にとって不可欠な選択肢となりつつあります。
Global Fast Melt Tablets Market size was valued at USD 5.6 billion in 2023 and is poised to grow from USD 6.1 billion in 2024 to USD 12.06 billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).
The fast-melting tablet market is experiencing growth due to the increasing demand for solid oral dosage forms that dissolve without the need for water or chewing. This innovative solution caters to active individuals, the elderly, and those with swallowing difficulties, ensuring drug accessibility in various scenarios. Recent advancements in oral-dissolving drug delivery systems have enhanced their capabilities, offering rapid intervention for drug therapy, improved bioavailability, and enhanced stability. Their user-friendly manufacturing process and consistent dosing make them ideal for handling conditions such as motion sickness, allergic attacks, or acute coughing, where a quick onset of action is essential. As a result, fast-dissolving tablets are becoming an essential option for diverse demographics seeking effective and convenient medication solutions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fast Melt Tablets market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Fast Melt Tablets Market Segmental Analysis
Global Fast Melt Tablets Market is segmented by Drug Class, Indication, Distribution channel and region. Based on Drug Class, the market is segmented into Anti-Psychotics, Anti-Epileptics, CNS Stimulants, Anxiolytics, Anti-Parkinsonian Drugs, Anti-Hypertensive, NSAIDS, Anti-Allergy Drugs, Proton Pump Inhibitors and Others. Based on Indication, the market is segmented into CNS Diseases, GI Diseases, CVS Disorders, Allergy and Others. Based on Distribution channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Drug Stores and Online Pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Fast Melt Tablets Market
The growth of the Global Fast Melt Tablets market is significantly influenced by several factors. Chief among these is the increasing aging population, many of whom struggle with swallowing traditional pills. The heightened focus on product promotion aimed at improving consumer awareness and patient care is also contributing to market dynamics. As patients seek cost-effective solutions that enhance their quality of life, the demand for fast melt tablets continues to rise. Furthermore, the risks associated with choking or asphyxiation from conventional oral solid formulations underscore the necessity for alternatives. Technological advancements have enabled the development of fast melt tablets that dissolve swiftly, often within three minutes, thereby aligning with pharmacopoeia standards and further driving market growth.
Restraints in the Global Fast Melt Tablets Market
One significant constraint impacting the global fast melt tablets market is the difficulty associated with handling these products. Due to their porous and delicately formed structure, fast melt tablets lack robustness and are often created with minimal compression, rendering them fragile and prone to breakage. This vulnerability complicates storage, transportation, and dispensing processes, ultimately hindering market expansion. As a result, manufacturers face challenges in ensuring product integrity, which could lead to increased costs and limitations in distribution. Addressing these handling concerns is essential for overcoming barriers to growth within the fast melt tablets sector.
Market Trends of the Global Fast Melt Tablets Market
The Global Fast Melt Tablets market is experiencing robust growth, primarily fueled by the increasing demand from the geriatric population, who favor these formulations for their convenience and rapid action. Fast melt tablets eliminate first-pass metabolism issues associated with traditional oral medications, enhancing bioavailability and patient adherence. As this demographic seeks efficient self-administration options with fewer side effects, the trend towards fast-dissolving doses is gaining momentum. While technical challenges in formulation exist, ongoing research and development efforts are anticipated to address these hurdles, presenting significant opportunities for market expansion in the coming years.